MXPA04007980A - Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea. - Google Patents

Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.

Info

Publication number
MXPA04007980A
MXPA04007980A MXPA04007980A MXPA04007980A MXPA04007980A MX PA04007980 A MXPA04007980 A MX PA04007980A MX PA04007980 A MXPA04007980 A MX PA04007980A MX PA04007980 A MXPA04007980 A MX PA04007980A MX PA04007980 A MXPA04007980 A MX PA04007980A
Authority
MX
Mexico
Prior art keywords
type
wafer
taste
medicinal preparation
masked film
Prior art date
Application number
MXPA04007980A
Other languages
English (en)
Inventor
Von Falkenhausen Christian
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MXPA04007980A publication Critical patent/MXPA04007980A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Abstract

La invencion se refiere a preparados farmaceuticos en forma de pelicula o de oblea de poco espesor para la administracion de principios activos, que se caracterizan por contener el preparado al menos un polimero formador de matriz, en el cual se encuentra disuelto o disperso al menos un principio activo y al menos un generador de dioxido de carbono.
MXPA04007980A 2002-02-21 2003-02-04 Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea. MXPA04007980A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10207394A DE10207394B4 (de) 2002-02-21 2002-02-21 Geschmacksmaskierte oblatenförmige Arzneizubereitung
PCT/EP2003/001052 WO2003070227A1 (de) 2002-02-21 2003-02-04 Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung

Publications (1)

Publication Number Publication Date
MXPA04007980A true MXPA04007980A (es) 2005-08-15

Family

ID=27740294

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007980A MXPA04007980A (es) 2002-02-21 2003-02-04 Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.

Country Status (17)

Country Link
US (1) US7615235B2 (es)
EP (1) EP1476140B1 (es)
JP (1) JP2005517722A (es)
KR (1) KR100874876B1 (es)
CN (1) CN1638748B (es)
AU (1) AU2003210202B2 (es)
BR (1) BR0307540A (es)
CA (1) CA2472967C (es)
DE (1) DE10207394B4 (es)
ES (1) ES2666475T3 (es)
IL (2) IL163653A0 (es)
MX (1) MXPA04007980A (es)
NZ (1) NZ534451A (es)
PL (1) PL371058A1 (es)
RU (1) RU2316316C2 (es)
WO (1) WO2003070227A1 (es)
ZA (1) ZA200405520B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
JP4643912B2 (ja) * 2004-01-30 2011-03-02 第一三共ヘルスケア株式会社 血流促進剤
US20050186257A1 (en) * 2004-02-20 2005-08-25 Todd Manegold Dissolvable film and method of manufacture
US20060207911A1 (en) * 2005-03-15 2006-09-21 Bullock John D Emergency medical treatment system
EP1937414A4 (en) * 2005-09-19 2013-01-02 Univ Witwatersrand Jhb PHARMACEUTICAL FORM FOR ORAL MUCOUSES
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
DE602007010254D1 (de) * 2006-03-16 2010-12-16 Novartis Ag Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
DE102006027793A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
DE102006027790A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Typ-2-Diabetes Kombinations-Wafer
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
DE102006027791A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag AchE-NMDA-Kombinationswafer
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
WO2008005534A2 (en) * 2006-07-06 2008-01-10 Forest Laboratories, Inc. Orally dissolving formulations of memantine
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
WO2008037809A1 (en) * 2006-09-29 2008-04-03 Abbott Gmbh & Co. Kg Transmucosal administration of fibrate compounds and delivery system therefor
JP4916894B2 (ja) * 2007-01-11 2012-04-18 株式会社ツキオカ フィルム状製剤及びフィルム状製剤の製造方法
EP2134321A2 (en) * 2007-03-07 2009-12-23 Novartis Ag Orally administrable films
EP2161021B1 (en) * 2007-06-07 2017-03-08 Sato Pharmaceutical Co. Ltd. Medicinal film preparation with rapidly dissolving property and flexibility
AU2008282892A1 (en) * 2007-07-31 2009-02-05 Bill Mcanalley And Associates, Llc Compositions, uses, and method of making wound care products from naturally occurring food ingredients
CN102014882A (zh) * 2008-01-31 2011-04-13 麦克内尔-Ppc股份有限公司 即刻释放活性成分的可食用膜条片
CN102014883A (zh) * 2008-01-31 2011-04-13 麦克内尔-Ppc股份有限公司 具有调释型活性成分的可食用膜条片
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
US8623401B2 (en) 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
WO2010023874A1 (ja) * 2008-08-25 2010-03-04 救急薬品工業株式会社 ロペラミド塩酸塩含有フィルム製剤
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
EP2419085A4 (en) * 2009-04-14 2013-04-24 Univ California IMPROVED DEVICES FOR ORAL MEDICINAL PRODUCTS AND MEDICINAL PRODUCTS
KR101074271B1 (ko) 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
WO2011019819A1 (en) 2009-08-12 2011-02-17 Forest Laboratories Holdings Limited Orally disintegrating compositions of linaclotide
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
KR101063130B1 (ko) 2009-10-12 2011-09-07 조영재 이산화탄소 발생 시트 및 이의 제조방법
US20220347095A1 (en) * 2009-10-30 2022-11-03 Ix Biopharma Ltd Solid Dosage Form
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US20110165254A1 (en) * 2010-01-07 2011-07-07 Knovation, Inc. Drug Delivery Using Fine Fiber Encapsulation
WO2011108643A1 (ja) * 2010-03-03 2011-09-09 救急薬品工業株式会社 不快な味を有する薬物を含有するフィルム製剤
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
WO2011154975A2 (en) 2010-06-08 2011-12-15 Cadila Healthcare Limited Pharmaceutical compositions of metformin
RU2535040C2 (ru) * 2010-07-02 2014-12-10 Дзе Проктер Энд Гэмбл Компани Способы доставки медицинского активного агента путем введения индивидуальных медицинских изделий, содержащих филамент
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US20130115266A1 (en) * 2011-11-04 2013-05-09 Bestsweet, Inc. Edible wafer-type product for delivery of nutraceuticals and pharmaceuticals
KR101188594B1 (ko) * 2011-12-06 2012-10-08 (주)씨엘팜 쓴맛이 차단된 실데나필 시트르산의 구강내 속붕해 필름제형
JP6149865B2 (ja) 2011-12-14 2017-06-21 エルテーエス ローマン テラピー−ジステーメ アーゲー フェノフィブラートのための強化された溶解速度を備えたウェーハ及びカプセル製剤
JP5841433B2 (ja) * 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
WO2013129889A2 (ko) 2012-02-28 2013-09-06 주식회사 서울제약 실데나필을 유효성분으로 함유하며 고미가 은폐된 고함량 속용필름
US20140272220A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Reduction in stress cracking of films
EP2815743A1 (en) * 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US20180104183A1 (en) * 2015-04-07 2018-04-19 Nipro Corporation Oral film preparation
KR101686821B1 (ko) 2015-05-18 2016-12-15 (주)선재하이테크 X선 발생기
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
DE102021100752A1 (de) 2021-01-15 2022-07-21 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767571A1 (de) 1968-06-04 1970-01-02 Farah Mfg Company Inc Waffelfoermiges Mundwaschmittel
IN142428B (es) * 1974-07-05 1977-07-09 Schering Ag
US4184888A (en) * 1978-03-01 1980-01-22 Dap Inc. Effervescent adhesive-forming product
US4639368A (en) 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
ZA932268B (en) * 1992-03-30 1993-11-11 Alza Corp Polymer system containing a partially soluble compound
IT1283029B1 (it) * 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
AU713462B2 (en) * 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
DE19635676A1 (de) 1996-09-03 1998-03-05 Basf Ag Feste geschäumte Wirkstoffzubereitungen
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
JP4346817B2 (ja) * 1997-09-30 2009-10-21 第一三共ヘルスケア株式会社 経口投与製剤
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US8765167B2 (en) * 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20060057207A1 (en) * 2001-11-30 2006-03-16 Pfizer Inc Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene

Also Published As

Publication number Publication date
KR100874876B1 (ko) 2008-12-19
CA2472967A1 (en) 2003-08-28
US7615235B2 (en) 2009-11-10
ZA200405520B (en) 2005-02-23
WO2003070227A1 (de) 2003-08-28
AU2003210202A1 (en) 2003-09-09
RU2316316C2 (ru) 2008-02-10
JP2005517722A (ja) 2005-06-16
DE10207394B4 (de) 2007-03-29
IL163653A (en) 2011-07-31
EP1476140A1 (de) 2004-11-17
PL371058A1 (en) 2005-06-13
AU2003210202B2 (en) 2009-01-29
DE10207394A1 (de) 2003-09-11
CN1638748A (zh) 2005-07-13
BR0307540A (pt) 2004-12-07
IL163653A0 (en) 2005-12-18
NZ534451A (en) 2006-11-30
US20050163830A1 (en) 2005-07-28
RU2004124720A (ru) 2005-06-10
WO2003070227A9 (de) 2004-04-01
CN1638748B (zh) 2010-08-25
ES2666475T3 (es) 2018-05-04
EP1476140B1 (de) 2018-04-04
KR20040089634A (ko) 2004-10-21
CA2472967C (en) 2011-07-12

Similar Documents

Publication Publication Date Title
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
WO2006133941A3 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
MXPA05006670A (es) Administracion de capsaicinoides.
WO2004089336A3 (en) Drug delivery systems comprising an encapsulated active ingredient
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
WO2005094799A3 (en) Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
MXPA05010196A (es) Nuevas formulaciones y su uso.
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
EP0966966A3 (en) Nefazodone dosage form
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
BG108516A (en) Pharmaceutical formulation
EP2308479A3 (en) Compounds and compositions for delivering active agents
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.

Legal Events

Date Code Title Description
FG Grant or registration